
Avinger Inc Investor Relations Material
Latest events

Q3 2024
Avinger Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avinger Inc
Access all reports
Avinger Inc. is a medical device company that develops and manufactures innovative catheter-based technologies for the treatment of peripheral artery disease (PAD). The company’s core products are image-guided, minimally invasive devices designed to help physicians diagnose and treat arterial blockages in the lower extremities. Avinger's proprietary technology, including its optical coherence tomography (OCT) imaging, enables real-time visualization of the artery during procedures, improving precision and outcomes for patients. The company focuses on advancing solutions that reduce the need for more invasive surgical interventions. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
AVGR
Country
🇺🇸 United States